Latest Breaking News On - Medical lifecycle team leader - Page 1 : comparemela.com

On December 8, Samsung Bioepis announced that it had presented the longest follow-up study results for a trastuzumab biosimilar in patients with HER2-positive early or locally advanced.

United statesSamsung bioepiSamsung bioepisAmerican society of hematologyLifecycle team leaderAntonio breast cancer symposiumAmerican societyAnnual meetingDong hoon shinVice presidentMedical lifecycle team leader